Try it
Psychiatry · Psychopharmacology: SSRI associated with QT prolongation
Sample itemA 68-year-old with depression is to start an SSRI, but she has a long QT interval on her ECG. Which SSRI carries a dose-dependent warning for QT prolongation and should be avoided?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Citalopram
Citalopram causes dose-dependent QT prolongation, and regulators limit its maximum dose, with a lower limit in people over 60. Sertraline is the preferred SSRI in cardiac disease.
Option by option
A. Paroxetine
Paroxetine is not noted for QT prolongation.
B. Sertraline
Sertraline has minimal QT effect and is preferred in cardiac disease.
C. Citalopram (correct)
Correct. Citalopram has a recognised dose-related QT warning.
D. Fluvoxamine
Fluvoxamine is not known for QT prolongation, though it has CYP interactions.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…
- Eating disordersA 17-year-old girl has a BMI of 15, amenorrhoea, lanugo hair, bradycardia and an intense…